NASH - NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NASH - NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NASH - NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to halt liver scarring in 2,150 patients with fatty liver disease
Disease control Recruiting nowThis phase 3 trial tests efruxifermin, a weekly injection, in 2,150 adults with liver scarring (cirrhosis) caused by NASH/MASH, a type of fatty liver disease. Half get the drug, half get a placebo. The goal is to see if efruxifermin can prevent serious liver events like liver fai…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Sleeve gastrectomy vs. lifestyle: which tames fatty liver disease?
Disease control Recruiting nowThis study compares two approaches for treating non-alcoholic steatohepatitis (NASH), a serious liver condition linked to obesity. Half of the 48 participants will receive vertical sleeve gastrectomy surgery along with lifestyle counseling, while the other half will get lifestyle…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can Weight-Loss surgery reverse severe fatty liver disease?
Disease control Recruiting nowThis study tests if weight-loss surgery is better than standard medical treatment for making nonalcoholic steatohepatitis (NASH) with advanced liver scarring disappear without making the scarring worse. It involves 100 obese adults with NASH and significant liver fibrosis. Partic…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New MRI scan could spare NASH patients painful liver biopsies
Diagnosis Recruiting nowThis study is testing a new, non-invasive MRI scan (called cT1) to see if it can accurately diagnose NASH, a serious liver disease. Currently, doctors need to take a small sample of liver tissue with a needle (biopsy) to confirm the diagnosis. The study will compare the MRI resul…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: Perspectum • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Mayo clinic probes hidden link between belly fat and liver damage
Knowledge-focused Recruiting nowThis study from Mayo Clinic looks at how inflammation in fat tissue may affect the liver in people with severe obesity. Researchers will measure liver stiffness and fat tissue markers in 60 adults before they have weight-loss surgery. The goal is to better understand why some peo…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC